Injective (INJ) is trading at $5.07 with a market cap of $506.87 million, showing signs of a potential recovery as accumulation grows near cycle lows. Analysts identify a high-probability long-term recovery zone, with the first major resistance target at $16.44. A breakout above this level could signal a new bull wave, with subsequent targets at $35.02 and $53.03. The project is advancing real-world asset (RWA) tokenization, providing scalable blockchain infrastructure for institutional adoption in a market projected to become a multi-trillion-dollar industry.
Injective is showing signs of a potential recovery as market conditions improve and accumulation interest grows, according to market data. The project is also strengthening its role in real-world asset tokenization by providing scalable blockchain infrastructure designed to support institutional adoption.
At the time of writing, INJ is trading at $5.07 with a 24-hour trading volume of $63.33 million and a market capitalization of $506.87 million. Despite a 1.87% loss over the last 24 hours, the price structure and network expansion point to a bullish reversal ahead.
An analyst, @TakeProfitNow, states that Injective is trading near its cycle lows, where the token is approaching a high-probability, long-term recovery zone. Although the price remains well below previous resistance levels, this area has historically attracted accumulation before major rallies. Declining selling pressure is strengthening expectations that bullish momentum could gradually return.
The first resistance level is established at $16.44 and, once broken, will signal a new bull wave. Analysts see a second resistance level at $35.02, while the third will be at $53.03, which almost coincides with the previous cycle high. If these resistances are all broken, there might be another period of price discovery.
Data from Injective highlights that real-world asset tokenization stands to be a multi-trillion-dollar industry as banks and financial institutions increasingly rely on blockchain technology. Through tokenization of stocks, bonds, real estate, and commodities, efficiency of markets increases, liquidity is enhanced, and settlements are accelerated. Injective is establishing itself in this domain by providing blockchain infrastructure that facilitates institutional adoption.
A decisive move past $16.44 would set off more bullish sentiment as Injective moves towards higher targets. Continued adoption of RWA, rising institutional interest, and ecosystem growth might contribute toward increased demand for INJ tokens.
